SPL Mapping FHIR R5 Implementation Guide, published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 0.2.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/fhir-spl/ and changes regularly. See the Directory of published versions
Page standards status: Informative |
Generated Narrative: Ingredient LantusIngredient2
status: Active
for: ManufacturedItemDefinition: status = active; manufacturedDoseForm = INJECTION, SOLUTION
role: inactive ingredient
substance
Codes
Concept METACRESOL Strengths
Presentation[x] 2.7 mg (Details: UCUM codemg = 'mg')/1 mL (Details: UCUM codemL = 'mL')